Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors
作者:Aliya Ibrar、Yildiz Tehseen、Imtiaz Khan、Abdul Hameed、Aamer Saeed、Norbert Furtmann、Jürgen Bajorath、Jamshed Iqbal
DOI:10.1016/j.bioorg.2016.08.005
日期:2016.10
the development of potent and selective inhibitors of aldose reductase (ALR2), and to control the diabetes mellitus (DM), a chronic metabolic disease, we synthesized novel coumarin-thiazole 6(a-o) and coumarin-oxadiazole 11(a-h) hybrids and screened for their inhibitory activity against aldose reductase (ALR2), for the selectivity against aldehyde reductase (ALR1). Compounds were also screened against
为了继续致力于开发有效和选择性的醛糖还原酶(ALR2)抑制剂,并控制糖尿病(DM)(一种慢性代谢疾病),我们合成了新型香豆素-噻唑6(ao)和香豆素-恶二唑11(ah)杂种并筛选其对醛糖还原酶(ALR2)的抑制活性,对醛还原酶(ALR1)的选择性。还针对ALR1筛选化合物。在新设计的化合物中,6c,11d和11g是ALR2的选择性抑制剂。而(E)-3-(2-(2-(2-溴苄叉基)肼基)噻唑-4-基)-2H-铬-2--2-酮6c对ALR2的最低IC50值为0.16±0.06μM。此外,化合物(E)-3-(2-(2-亚苄叉肼基)噻唑-4-基)-2H-铬-2--2-酮(6a; ARL1的IC50 = 2.94±1.23μM,0.12±0。ARL2)和(E)-3-(2-(2-(2-(1-(4-溴苯基)亚乙基)肼基)噻唑-4-基)-2H-铬-2-酮(6e; IC50 = 1.71±05μM ARL1的0